Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft‐versus‐host disease
- 1 October 1999
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 107 (1) , 169-175
- https://doi.org/10.1046/j.1365-2141.1999.01675.x
Abstract
Development of acute graft‐versus‐host disease (aGVHD) following HLA‐identical sibling bone marrow transplantation (BMT) remains a serious complication. Aselective depletion of T cells has proved to be effective in preventing aGVHD but is associated with relapse and increased incidence of infection. As aGVHD is directed mainly against epithelial tissues we examined whether it would be feasible to selectively deplete T cells reactive with epithelial cells whilst preserving other specificities. Donor T cells which express HLA‐DR, CD25, CD69 and CD71 activation markers after cocultivation with patient keratinocytes were depleted using magnetic cell separation techniques. Depletion of major as well as minor histocompatibility antigen activated T cells revealed a significant (P = 0.004 and P = 0.031, respectively) 10‐fold decrease in the frequency of donor T lymphocyte precursors reactive with patient keratinocytes. The frequency reactive with third‐party and patient peripheral blood mononuclear cells, including leukaemia cells, remained unchanged, supporting the notion that aGVHD and graft‐versus‐leukaemia (GVL) may be separable. This alloantigen‐specific depletion may be used in matched unrelated as well as HLA‐identical sibling BMT for reducing aGVHD whilst conserving GVL.Keywords
This publication has 24 references indexed in Scilit:
- Specific depletion of alloreactive T cells in HLA‐identical siblings: a method for separating graft‐versus‐host and graft‐versus‐leukaemia reactionsBritish Journal of Haematology, 1998
- Much ado about minor histocompatibility antigensImmunology Today, 1998
- Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phaseBone Marrow Transplantation, 1997
- Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantationBone Marrow Transplantation, 1997
- Recent advances in graft‐versus‐host disease (GVHD) preventionImmunological Reviews, 1997
- Preferential usage of T cell receptor (TCR) V β by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host diseaseBone Marrow Transplantation, 1997
- Human B7-1 is more efficient than B7-2 in providing co-stimulation for alloantigen-specific T cellsEuropean Journal of Immunology, 1996
- THE TISSUE EXPRESSION OF CYTOKINES IN HUMAN ACUTE CUTANEOUS GRAFT-VERSUS-HOST DISEASETransplantation, 1995
- Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantationThe Lancet, 1993
- Host-Specific Interleukin-2–Secreting Donor T-Cell Precursors as Predictors of Acute Graft-versus-Host Disease in Bone Marrow Transplantation between HLA-Identical SiblingsNew England Journal of Medicine, 1992